Reuters logo
BRIEF-Galena Biopharma enters into merger agreement with Sellas Life Sciences Group
2017年8月8日 / 上午10点16分 / 4 个月前

BRIEF-Galena Biopharma enters into merger agreement with Sellas Life Sciences Group

Aug 8 (Reuters) - Galena Biopharma Inc

* Galena Biopharma enters into merger agreement with Sellas Life Sciences Group

* Galena Biopharma Inc - under terms of merger agreement, existing sellas shareholders will receive newly issued shares of Galena common stock

* Galena Biopharma Inc - ‍under terms of merger agreement, existing Sellas shareholders will receive newly issued shares of Galena common stock​

* Galena Biopharma Inc - on a pro forma basis, assuming completion of proposed merger, Galena stock and warrant holders are expected to own about 32.5%

* Galena Biopharma Inc - on pro forma basis, assuming completion of proposed merger, Sellas shareholders will own approximately 67.5% of combined co

* Galena Biopharma - Galena stock and warrant holders are expected to own about 32.5%, and sellas shareholders will own approximately 67.5% of combined company

* Galena Biopharma- ‍entered an all stock definitive merger agreement under which Sellas will merge into and become an indirect, wholly-owned unit of co​

* Galena Biopharma Inc - transaction has also been unanimously approved by sellas board of directors

* Galena Biopharma Inc - a majority of Sellas shareholders have agreed to vote in favor of transaction

* Galena Biopharma Inc - upon closing of transaction, name of combined company will become Sellas Life Sciences Group Inc

* Galena Biopharma - upon closing of transaction shares of combined are expected to continue trading on Nasdaq capital market under new ticker symbol SLS Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below